← Leaderboards
Fei Du
Mclean Hospital
$6,859,154
Attributed
$12,858,059
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2011–25$2.5M$1.9M$1.3M$625K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,858,059 · 6
By mechanism
R01$11,997,810 · 4
R21$860,249 · 2
Top collaborators
- Dost Ongur7 shared
- Brent Peter Forester6 shared
- Diego A. Pizzagalli5 shared
Most similar at Mclean Hospital
Same institution · by research overlap
- Dost Ongur$17,996,987
- Brent Peter Forester$10,348,605
- Abdullah Cagri Yuksel$852,450
- Sabina Berretta$31,866,827
- Jaymin A Upadhyay$925,949
Others in their field
Top investigators on “Bioenergetics”
- Jianyi Zhang · University Of Alabama At Birmingham$19,699,633
- Roberta Diaz Brinton · University Of Arizona$19,318,243
- Klaus H. Kaestner · University Of Pennsylvania$18,516,512
- Ali Naji · University Of Pennsylvania$18,516,512
- Russell H Swerdlow · University Of Kansas Medical Center$16,632,343
- Bruce M Spiegelman · Dana-Farber Cancer Inst$15,671,159
Research focus
BioenergeticsBrainFunctional DisorderOxidation-ReductionGlutathioneIn VivoMolecularPrefrontal CortexMedialOxidative StressEquilibriumEnergy MetabolismLinkCreatine KinaseMental DisordersSchizophreniaMagnetic Resonance SpectroscopyMetabolicNadhMeasurementCognitionCognitiveFutureAlzheimer&Apos
Grant awards (22)
Molecular Mechanisms of Aging in Schizophrenia: Implications of Bioenergetic Metabolism and Redox Biology$762,422
R01 · FY2025 · MH · contact PI
Molecular Mechanisms of Aging in Schizophrenia: Implications of Bioenergetic Metabolism and Redox Biology$844,822
R01 · FY2024 · MH · contact PI
Effects of Orally Administered Nicotinamide Riboside on Bioenergetic Metabolism, Oxidative Stress and Cognition in Mild Cognitive Impairment and Mild Alzheimer's Dementia$819,553
R01 · FY2024 · AG · contact PI
Early Life Stress and Depression: Molecular and Functional Imaging Approaches$778,023
R01 · FY2024 · MH · contact PI
Effects of Orally Administered Nicotinamide Riboside on Bioenergetic Metabolism, Oxidative Stress and Cognition in Mild Cognitive Impairment and Mild Alzheimer's Dementia$886,282
R01 · FY2023 · AG · contact PI
Early Life Stress and Depression: Molecular and Functional Imaging Approaches$778,984
R01 · FY2023 · MH
Molecular Mechanisms and Biomarkers for Disease Progression from Prodrome to Early Psychosis$424,079
R01 · FY2023 · MH · contact PI
Effects of Orally Administered Nicotinamide Riboside on Bioenergetic Metabolism, Oxidative Stress and Cognition in Mild Cognitive Impairment and Mild Alzheimer's Dementia$886,282
R01 · FY2022 · AG · contact PI
Early Life Stress and Depression: Molecular and Functional Imaging Approaches$774,310
R01 · FY2022 · MH
Molecular Mechanisms and Biomarkers for Disease Progression from Prodrome to Early Psychosis$496,117
R01 · FY2022 · MH · contact PI
Early Life Stress and Depression: Molecular and Functional Imaging Approaches$772,752
R01 · FY2021 · MH
Effects of Orally Administered Nicotinamide Riboside on Bioenergetic Metabolism, Oxidative Stress and Cognition in Mild Cognitive Impairment and Mild Alzheimer's Dementia$554,992
R01 · FY2021 · AG · contact PI
Molecular Mechanisms and Biomarkers for Disease Progression from Prodrome to Early Psychosis$496,117
R01 · FY2021 · MH · contact PI
Effects of Orally Administered Nicotinamide Riboside on Bioenergetic Metabolism, Oxidative Stress and Cognition in Mild Cognitive Impairment and Mild Alzheimer's Dementia$313,981
R01 · FY2021 · AG · contact PI
Early Life Stress and Depression: Molecular and Functional Imaging Approaches$819,579
R01 · FY2020 · MH
Effects of Orally Administered Nicotinamide Riboside on Bioenergetic Metabolism, Oxidative Stress and Cognition in Mild Cognitive Impairment and Mild Alzheimer's Dementia$561,552
R01 · FY2020 · AG · contact PI
Molecular Mechanisms and Biomarkers for Disease Progression from Prodrome to Early Psychosis$514,703
R01 · FY2020 · MH · contact PI
Molecular Mechanisms and Biomarkers for Disease Progression from Prodrome to Early Psychosis$513,260
R01 · FY2019 · MH · contact PI
Oxidative Stress in First Episode Schizophrenia Assessed in vivo Using NAD+ and NADH Measurement$205,000
R21 · FY2018 · MH · contact PI
Oxidative Stress in First Episode Schizophrenia Assessed in vivo Using NAD+ and NADH Measurement$245,500
R21 · FY2017 · MH · contact PI
Novel 31P MRS Approach for Measuring Abnormal Bioenergetics in Schizophrenia$217,285
R21 · FY2012 · MH · contact PI
Novel 31P MRS Approach for Measuring Abnormal Bioenergetics in Schizophrenia$192,464
R21 · FY2011 · MH · contact PI